Genomic landscape of the DHA1 family in the newly emerged pathogen Candida auris and mapping substrate repertoire of the prominent member CauMdr1

The last decade has witnessed the rise of extremely threatening healthcare-associated multidrug resistant non-albicans Candida (NAC) species, Candida auris. Thus, understanding the molecular basis of antifungal resistance has emerged as the single most important goal amongst the research community. Since besides target alterations, efflux mechanisms contribute maximally to antifungal resistance, it is imperative to investigate their contributions in this pathogen. Of note, within the Major Facilitator Superfamily (MFS) of efflux pumps, Drug/H+ antiporter family 1 (DHA1) has been established as a predominant contributor towards xenobiotic efflux. Our study provides a complete landscape of DHA1 transporters encoded in the genome of C. auris. This study identifies 14 DHA1 transporters encoded in the genome of the pathogen. We also construct deletion and heterologous overexpression strains for the most important DHA1 drug transporter, viz., CauMdr1 to map the spectrum of its substrates. While the knockout strain did not show any significant changes in the resistance patterns against the majority of the tested substrates, the ortholog when overexpressed in a minimal background S. cerevisiae strain, AD1-8u-, showed significant enhancement in the Minimum inhibitory concentrations (MICs) against a large panel of antifungal molecules. Altogether, the present study provides a comprehensive template for investigating the role of DHA1 members of C. auris in antifungal resistance mechanisms.

[1]  Christina A. Cuomo,et al.  In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris , 2021, bioRxiv.

[2]  P. Schläpfer,et al.  DomainViz: intuitive visualization of consensus domain distributions across groups of proteins , 2021, Nucleic Acids Res..

[3]  K. Kuchler,et al.  Transcriptome Signatures Predict Phenotypic Variations of Candida auris , 2021, Frontiers in Cellular and Infection Microbiology.

[4]  D. Sanglard,et al.  Novel ERG11 and TAC1b Mutations Associated with Azole Resistance in Candida auris , 2021, Antimicrobial Agents and Chemotherapy.

[5]  A. Chakrabarti,et al.  On the emergence, spread and resistance of Candida auris: host, pathogen and environmental tipping points , 2021, Journal of medical microbiology.

[6]  R. Prasad,et al.  Directed Mutational Strategies Reveal Drug Binding and Transport by the MDR Transporters of Candida albicans , 2021, Journal of fungi.

[7]  Andrew M. Lynn,et al.  ABC-finder: A containerized web server for the identification and topology prediction of ABC proteins , 2020, bioRxiv.

[8]  A. Lorenz,et al.  What do we know about the biology of the emerging fungal pathogen of humans Candida auris? , 2020, Microbiological research.

[9]  Guanghua Huang,et al.  Candida auris: Epidemiology, biology, antifungal resistance, and virulence , 2020, PLoS pathogens.

[10]  Christina A. Cuomo,et al.  Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance , 2020, mBio.

[11]  A. Bonifaz,et al.  Antifungal Resistance in Candida auris: Molecular Determinants , 2020, Antibiotics.

[12]  Christina A. Cuomo,et al.  Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris , 2020, mBio.

[13]  Marie-Franqoise Paul,et al.  Saccharomyces cerevisiae , 2020, Catalysis from A to Z.

[14]  Christina A. Cuomo,et al.  Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses , 2020, mBio.

[15]  A. Mondal,et al.  Cdr1p highlights the role of the non-hydrolytic ATP-binding site in driving drug translocation in asymmetric ABC pumps. , 2019, Biochimica et biophysica acta. Biomembranes.

[16]  R. Prasad,et al.  Multidrug transporters of Candida species in clinical azole resistance. , 2019, Fungal genetics and biology : FG & B.

[17]  H. Badali,et al.  Potential Fifth Clade of Candida auris, Iran, 2018 , 2019, Emerging infectious diseases.

[18]  N. Gow,et al.  ABC Transporter Genes Show Upregulated Expression in Drug-Resistant Clinical Isolates of Candida auris: A Genome-Wide Characterization of ATP-Binding Cassette (ABC) Transporter Genes , 2019, Front. Microbiol..

[19]  Sneha P. Couvillion,et al.  Multi-omics Signature of Candida auris, an Emerging and Multidrug-Resistant Pathogen , 2019, mSystems.

[20]  K. Barker,et al.  Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris , 2019, Antimicrobial Agents and Chemotherapy.

[21]  Christina A. Cuomo,et al.  Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species , 2018, Nature Communications.

[22]  R. Prasad,et al.  Phylogenetic and conservation analyses of MFS transporters , 2018, 3 Biotech.

[23]  H. Gohlke,et al.  FK506 Resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 Involves Mutations in the Transmembrane Domains and Extracellular Loops , 2018, Antimicrobial Agents and Chemotherapy.

[24]  A. Borman,et al.  Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance , 2018, mSphere.

[25]  Sudhir Kumar,et al.  MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. , 2018, Molecular biology and evolution.

[26]  A. Chowdhary,et al.  A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance , 2018, The Journal of antimicrobial chemotherapy.

[27]  P. Falson,et al.  Molecular Basis of Substrate Polyspecificity of the Candida albicans Mdr1p Multidrug/H+ Antiporter. , 2018, Journal of molecular biology.

[28]  Cristina Aurrecoechea,et al.  FungiDB: An Integrated Bioinformatic Resource for Fungi and Oomycetes , 2018, Journal of fungi.

[29]  R. Prasad,et al.  Resistance to antifungal therapies. , 2017, Essays in biochemistry.

[30]  A. Borman,et al.  Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris , 2017, Emerging infectious diseases.

[31]  Christina A. Cuomo,et al.  Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  R. Prasad,et al.  MFS transporters of Candida species and their role in clinical drug resistance. , 2016, FEMS yeast research.

[33]  Evan W. Floden,et al.  PSI/TM-Coffee: a web server for fast and accurate multiple sequence alignments of regular and transmembrane proteins using homology extension on reduced databases , 2016, Nucleic Acids Res..

[34]  Miguel C. Teixeira,et al.  Membrane Proteome-Wide Response to the Antifungal Drug Clotrimazole in Candida glabrata: Role of the Transcription Factor CgPdr1 and the Drug:H+ Antiporters CgTpo1_1 and CgTpo1_2* , 2015, Molecular & Cellular Proteomics.

[35]  R. Prasad,et al.  The ABCs of Candida albicans Multidrug Transporter Cdr1 , 2015, Eukaryotic Cell.

[36]  P. Dias,et al.  Phylogenetic and syntenic analyses of the 12-spanner drug:H(+) antiporter family 1 (DHA1) in pathogenic Candida species: evolution of MDR1 and FLU1 genes. , 2014, Genomics.

[37]  Rupinder Kaur,et al.  Novel role of a family of major facilitator transporters in biofilm development and virulence of Candida albicans. , 2014, The Biochemical journal.

[38]  Miguel C. Teixeira,et al.  Candida glabrata Drug:H+ Antiporter CgQdr2 Confers Imidazole Drug Resistance, Being Activated by Transcription Factor CgPdr1 , 2013, Antimicrobial Agents and Chemotherapy.

[39]  Rohitash Kumar,et al.  Candida albicans Flu1-Mediated Efflux of Salivary Histatin 5 Reduces Its Cytosolic Concentration and Fungicidal Activity , 2013, Antimicrobial Agents and Chemotherapy.

[40]  Sean R Eddy,et al.  A new generation of homology search tools based on probabilistic inference. , 2009, Genome informatics. International Conference on Genome Informatics.

[41]  Miguel C. Teixeira,et al.  Drug:H+ antiporters in chemical stress response in yeast. , 2009, Trends in microbiology.

[42]  Y. Uehara,et al.  Characterization of Three Classes of Membrane Proteins Involved in Fungal Azole Resistance by Functional Hyperexpression in Saccharomyces cerevisiae , 2007, Eukaryotic Cell.

[43]  Miguel C. Teixeira,et al.  The yeast multidrug transporter Qdr3 (Ybr043c): localization and role as a determinant of resistance to quinidine, barban, cisplatin, and bleomycin. , 2005, Biochemical and biophysical research communications.

[44]  D. Sanglard,et al.  TAC1, Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2 , 2004, Eukaryotic Cell.

[45]  Sandra Tenreiro,et al.  Saccharomyces cerevisiae Aqr1 Is an Internal-Membrane Transporter Involved in Excretion of Amino Acids , 2004, Eukaryotic Cell.

[46]  Miguel C. Teixeira,et al.  Saccharomyces cerevisiae Multidrug Transporter Qdr2p (Yil121wp): Localization and Function as a Quinidine Resistance Determinant , 2004, Antimicrobial Agents and Chemotherapy.

[47]  K. Barker,et al.  Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae. , 2003, The Journal of antimicrobial chemotherapy.

[48]  Sandra Tenreiro,et al.  Dtr1p, a Multidrug Resistance Transporter of the Major Facilitator Superfamily, Plays an Essential Role in Spore Wall Maturation in Saccharomyces cerevisiae , 2002, Eukaryotic Cell.

[49]  T. Yamada-Okabe,et al.  Characterization of the CaNAG3, CaNAG4, and CaNAG6 genes of the pathogenic fungus Candida albicans: possible involvement of these genes in the susceptibilities of cytotoxic agents. , 2002, FEMS microbiology letters.

[50]  Miguel C. Teixeira,et al.  AQR1 gene (ORF YNL065w) encodes a plasma membrane transporter of the major facilitator superfamily that confers resistance to short-chain monocarboxylic acids and quinidine in Saccharomyces cerevisiae. , 2002, Biochemical and biophysical research communications.

[51]  S. Tenreiro,et al.  Resistance and Adaptation to Quinidine in Saccharomyces cerevisiae: Role of QDR1 (YIL120w), Encoding a Plasma Membrane Transporter of the Major Facilitator Superfamily Required for Multidrug Resistance , 2001, Antimicrobial Agents and Chemotherapy.

[52]  D. Sanglard,et al.  A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. , 2000, Microbiology.

[53]  A. Goffeau,et al.  ATPase and Multidrug Transport Activities of the Overexpressed Yeast ABC Protein Yor1p* , 1998, The Journal of Biological Chemistry.

[54]  M. Raymond,et al.  AP1-mediated Multidrug Resistance in Saccharomyces cerevisiae Requires FLR1 Encoding a Transporter of the Major Facilitator Superfamily* , 1997, The Journal of Biological Chemistry.

[55]  G. Fink,et al.  HOL1 mutations confer novel ion transport in Saccharomyces cerevisiae. , 1990, Molecular and cellular biology.

[56]  G. Ruiz,et al.  What do we know about the biology of the emerging fungal pathogen of humans , 2020 .

[57]  A. Bharat,et al.  Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses , 2020 .